Literature DB >> 14319166

[TREATMENT OF EXPERIMENTAL INFECTION BY MYCOBACTERIUM ULCERANS AND MYCOBACTERIUM BALNEI IN MICE].

S R PATTYN, J ROYACKERS.   

Abstract

Entities:  

Keywords:  EXPERIMENTAL LAB STUDY; MICE; MYCOBACTERIUM INFECTIONS; PHARMACOLOGY

Mesh：

Year:  1965        PMID： 14319166

Source DB:  PubMed          Journal:  Ann Soc Belges Med Trop Parasitol Mycol        ISSN： 0037-9638


× No keyword cloud information.
  7 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

2.  Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system.

Authors:  J C Palomino; F Portaels
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Activities of several antimicrobials against Mycobacterium ulcerans infection in mice.

Authors:  H Dega; J Robert; P Bonnafous; V Jarlier; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

4.  Findings from a buruli ulcer mouse model study.

Authors:  P Addo; E Owusu; B Adu-Addai; M Quartey; M Abbas; A Dodoo; D Ofori-Adjei
Journal:  Ghana Med J       Date:  2005-09

5.  Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer.

Authors:  Paul J Converse; Deepak V Almeida; Eric L Nuermberger
Journal:  Methods Mol Biol       Date:  2022

6.  Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.

Authors:  Herve Dega; Abdelhalim Bentoucha; Jerome Robert; Vincent Jarlier; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  In vitro susceptibility of Mycobacterium ulcerans to clarithromycin.

Authors:  F Portaels; H Traore; K De Ridder; W M Meyers
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.